CrystalGenomics, Inc. (083790.KQ)

KRW 2545.0

(0.99%)

Eps Summary of CrystalGenomics, Inc.

CrystalGenomics, Inc.'s latest annual eps in 2023 was -661.00 KRW , down -93.01% from previous year.
CrystalGenomics, Inc.'s latest quarterly eps in 2024 Q2 was -186.21 KRW , down -88.78% from previous quarter.
CrystalGenomics, Inc. reported an annual eps of -345.00 KRW in 2022, down -48.71% from previous year.
CrystalGenomics, Inc. reported an annual eps of -232.00 KRW in 2021, down -88.11% from previous year.
CrystalGenomics, Inc. reported a quarterly eps of -98.15 KRW for 2024 Q1, up 77.02% from previous quarter.
CrystalGenomics, Inc. reported a quarterly eps of N/A for 2023 FY, down -93.01% from previous quarter.

Annual Eps Chart of CrystalGenomics, Inc. (2023 - 2013)

Historical Annual Eps of CrystalGenomics, Inc. (2023 - 2013)

Year	Eps	Eps Growth
2023	-661.00 KRW	-93.01%
2022	-345.00 KRW	-48.71%
2021	-232.00 KRW	-88.11%
2020	-123.33 KRW	-556.95%
2019	-627.33 KRW	10.66%
2018	124.67 KRW	10.66%
2017	-166.24 KRW	8.3%
2016	-43.48 KRW	12.93%
2015	-104.47 KRW	14.12%
2014	-289.29 KRW	13.6%
2013	-315.41 KRW	0.0%

Year	Eps	Eps Growth
2024 Q2	-186.21 KRW	-88.78%
2024 Q1	-98.15 KRW	77.02%
2023 FY	- USD	-93.01%
2023 Q1	-63.24 USD	-994.48%
2023 Q3	284.00 USD	160.04%
2023 Q2	-473.00 KRW	-647.94%
2023 Q4	-417.36 USD	-246.96%
2022 FY	- USD	-48.71%
2022 Q3	11.65 USD	0.0%
2022 Q1	8.79 USD	27.39%
2022 Q4	7.07 USD	-39.31%
2021 Q4	6.90 USD	-39.95%
2021 FY	- USD	-88.11%
2021 Q1	8.61 USD	24.24%
2021 Q3	11.49 USD	0.0%
2020 Q1	7.20 USD	0.7%
2020 Q3	11.60 USD	0.0%
2020 Q4	6.93 USD	-40.26%
2020 FY	- USD	-556.95%
2019 Q1	8.00 USD	39.13%
2019 Q3	11.30 USD	0.0%
2019 FY	- USD	10.66%
2019 Q4	7.15 USD	-36.73%
2018 Q4	5.75 USD	-23.44%
2018 FY	- USD	10.66%
2018 Q3	7.51 USD	0.0%
2018 Q1	6.71 USD	29.29%
2017 FY	- USD	8.3%
2017 Q1	5.72 USD	41.58%
2017 Q3	7.63 USD	0.0%
2017 Q4	5.19 USD	-31.98%
2016 FY	- USD	12.93%
2016 Q4	4.04 USD	-43.5%
2016 Q3	7.15 USD	0.0%
2016 Q1	5.39 USD	44.89%
2015 Q3	6.38 USD	0.0%
2015 Q1	4.79 USD	31.59%
2015 FY	- USD	14.12%
2015 Q4	3.72 USD	-41.69%
2014 FY	- USD	13.6%
2014 Q1	4.23 USD	34.29%
2014 Q3	5.64 USD	0.0%
2014 Q4	3.64 USD	-35.46%
2013 Q1	3.64 USD	52.3%
2013 Q4	3.15 USD	-39.54%
2013 FY	- USD	0.0%
2013 Q3	5.21 USD	0.0%
2012 Q4	2.39 USD	0.0%

Peer Eps Comparison of CrystalGenomics, Inc.

Name	Eps	Eps Difference
HLB Co., Ltd.	-1559.61 KRW	57.618%
iNtRON Biotechnology, Inc.	-292.11 KRW	-126.285%
BINEX Co., Ltd.	151.04 KRW	537.632%
Bioneer Corporation	-410.19 KRW	-61.145%
Anterogen.Co.,Ltd.	-291.93 KRW	-126.424%
MEDIPOST Co., Ltd.	287.00 KRW	330.314%
Helixmith Co., Ltd	-1543.76 KRW	57.182%
Chabiotech Co.,Ltd.	-149.80 KRW	-341.255%
Medy-Tox Inc.	1456.65 KRW	145.378%
Peptron, Inc.	-773.61 KRW	14.556%
Amicogen, Inc.	-583.58 KRW	-13.266%
Genexine, Inc.	-1652.14 KRW	59.991%
HLB Therapeutics Co.,Ltd.	-32.12 KRW	-1957.908%
LegoChem Biosciences, Inc.	-2595.00 KRW	74.528%
ALTEOGEN Inc.	-65.27 KRW	-912.716%
PharmaResearch Co., Ltd.	7502.00 KRW	108.811%
SillaJen, Inc.	-179.98 KRW	-267.263%
JETEMA, Co., Ltd.	783.21 KRW	184.396%
OliX Pharmaceuticals,Inc	-1323.81 KRW	50.068%
Genomictree Inc.	-391.00 KRW	-69.054%
MedPacto, Inc.	-1664.87 KRW	60.297%
D&D Pharmatech	409.19 KRW	261.539%
EASY BIO,Inc.	455.00 KRW	245.275%
GI Innovation, Inc.	-1285.69 KRW	48.588%